Literature DB >> 12187335

Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine.

Jean-Philippe Durand1, François Goldwasser.   

Abstract

Venlafaxine is an antidepressant which acts through the inhibition of the reuptake of norepinephrine and serotonin. Venlafaxine is active against neuropathic and chronic pain. We report the case of a 69-year-old woman who presented a paclitaxel-induced neuropathy. She presented paresthesias, pin pricks in both hands with functional impairment. Venlafaxine hydrochloride was introduced at 37.5 mg twice daily. The patient noticed a dramatic recovery of her symptoms within 2 days, with both reduction of the paresthesias and functional improvement. This is the first report of efficacious use of venlafaxine for the treatment of paclitaxel cumulative neurosensory toxicity. Copyright 2002 Lippincott Williams & Wilkins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12187335     DOI: 10.1097/00001813-200208000-00013

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  7 in total

Review 1.  Venlafaxine for neuropathic pain in adults.

Authors:  Helen C Gallagher; Ruth M Gallagher; Michelle Butler; Donal J Buggy; Martin C Henman
Journal:  Cochrane Database Syst Rev       Date:  2015-08-23

2.  Local Sympathectomy Promotes Anti-inflammatory Responses and Relief of Paclitaxel-induced Mechanical and Cold Allodynia in Mice.

Authors:  Raquel Tonello; Wenrui Xie; Sang Hoon Lee; Min Wang; Xiaojuan Liu; Judith A Strong; Jun-Ming Zhang; Temugin Berta
Journal:  Anesthesiology       Date:  2020-06       Impact factor: 7.892

Review 3.  Therapeutic strategies for cancer treatment related peripheral neuropathies.

Authors:  Deirdre R Pachman; James C Watson; Charles L Loprinzi
Journal:  Curr Treat Options Oncol       Date:  2014-12

Review 4.  Neuropathic cancer pain: What we are dealing with? How to manage it?

Authors:  Ece Esin; Suayib Yalcin
Journal:  Onco Targets Ther       Date:  2014-04-17       Impact factor: 4.147

5.  New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Janet Schloss; Maree Colosimo; Luis Vitetta
Journal:  Asia Pac J Oncol Nurs       Date:  2016 Jan-Mar

Review 6.  Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Hana Starobova; Irina Vetter
Journal:  Front Mol Neurosci       Date:  2017-05-31       Impact factor: 5.639

Review 7.  Management options for established chemotherapy-induced peripheral neuropathy.

Authors:  Deirdre R Pachman; James C Watson; Maryam B Lustberg; Nina D Wagner-Johnston; Alexandre Chan; Larry Broadfield; Yin Ting Cheung; Christopher Steer; Dawn J Storey; Kavita D Chandwani; Judith Paice; Pascal Jean-Pierre; Jeong Oh; Jayesh Kamath; Marie Fallon; Herwig Strik; Susanne Koeppen; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2014-05-31       Impact factor: 3.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.